South San Francisco, California (CA) Pharmaceuticals Companies
Featured companies
Not satisfied? Select a reason•Rate this page•Send feedback
Or try our search form or quick navigation by category and location
Oncology Thrputics Netwrk Corp
395 Oyster Point Blvd # 405
South San Francisco CA 94080
(650) 952-8400
Mckesson Specialty Care Solutions
395 Oyster Point Boulevard
South San Francisco CA 94080
(866) 686-8340
Hyperion Therapeutics Inc is a publicly held company in South San Francisco, CA and is a Headquarters business.
Sunesis Pharmaceuticals Inc
395 Oyster Point Boulevard # 400
South San Francisco CA 94080
(650) 266-3500
Sunesis Pharmaceuticals Inc is a publicly held company in South San Francisco, CA and is a Headquarters business.
Synergia Pharma is a privately held company in South San Francisco, CA and is a Single Location business.
Theravance Biopharma Antibiotics Inc
901 Gateway Boulevard
South San Francisco CA 94080
(877) 275-6930
Titan Pharmaceuticals Inc
400 Oyster Point Boulevard # 505
South San Francisco CA 94080
(650) 244-4990
Velocity Pharmaceutical Devmnt
400 Oyster Point Boulevard
South San Francisco CA 94080
(650) 745-8179
Mc Kesson Specialty Health
395 Oyster Point Boulevard # 500
South San Francisco CA 94080
(650) 952-8400
Whereorg has 101 results under Pharmaceuticals Companies in South San Francisco, CA.
Narrow down the browsing criteria below to see more companies.
Select a category for location San Mateo, California
Other locations for category Pharmaceuticals
- Atherton3
- Belmont7
- Brisbane9
- Burlingame44
- Colma1
- Daly City37
- Foster City13
Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020